BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15664192)

  • 21. Atypical transcriptional regulators and cofactors of PPARgamma.
    Miard S; Fajas L
    Int J Obes (Lond); 2005 Mar; 29 Suppl 1():S10-2. PubMed ID: 15711575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis.
    Jiang Z; Liang P; Leng R; Guo Z; Liu Y; Liu X; Bubnic S; Keating A; Murray D; Goss P; Zacksenhaus E
    Dev Biol; 2000 Nov; 227(1):8-41. PubMed ID: 11076674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
    Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
    Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
    Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
    Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation.
    Singh P; Wong SH; Hong W
    EMBO J; 1994 Jul; 13(14):3329-38. PubMed ID: 8045262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina.
    Kastner A; Espanel X; Brun G
    Cell Growth Differ; 1998 Oct; 9(10):857-67. PubMed ID: 9790497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p14ARF links the tumour suppressors RB and p53.
    Bates S; Phillips AC; Clark PA; Stott F; Peters G; Ludwig RL; Vousden KH
    Nature; 1998 Sep; 395(6698):124-5. PubMed ID: 9744267
    [No Abstract]   [Full Text] [Related]  

  • 29. Geminin is targeted for repression by the retinoblastoma tumor suppressor pathway through intragenic E2F sites.
    Markey M; Siddiqui H; Knudsen ES
    J Biol Chem; 2004 Jul; 279(28):29255-62. PubMed ID: 15084580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ATM is a target for positive regulation by E2F-1.
    Berkovich E; Ginsberg D
    Oncogene; 2003 Jan; 22(2):161-7. PubMed ID: 12527885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53.
    Maehara K; Yamakoshi K; Ohtani N; Kubo Y; Takahashi A; Arase S; Jones N; Hara E
    J Cell Biol; 2005 Feb; 168(4):553-60. PubMed ID: 15716376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E2F1 is crucial for E2F-dependent apoptosis.
    Lazzerini Denchi E; Helin K
    EMBO Rep; 2005 Jul; 6(7):661-8. PubMed ID: 15976820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
    Hu X; Cress WD; Zhong Q; Zuckerman KS
    Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The nucleocytoplasmic shuttling of E2F4 is involved in the regulation of human intestinal epithelial cell proliferation and differentiation.
    Deschênes C; Alvarez L; Lizotte ME; Vézina A; Rivard N
    J Cell Physiol; 2004 May; 199(2):262-73. PubMed ID: 15040009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice.
    Yamasaki L; Bronson R; Williams BO; Dyson NJ; Harlow E; Jacks T
    Nat Genet; 1998 Apr; 18(4):360-4. PubMed ID: 9537419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p120-v-Abl expression overcomes TGF-beta1 negative regulation of c-myc transcription but not cell growth.
    Birchenall-Roberts MC; Kim SJ; Bertolette DC; Turley JM; Fu T; Bang OS; Kasper JJ; Yoo YD; Ruscetti FW
    Oncogene; 1996 Oct; 13(7):1499-509. PubMed ID: 8875988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of Rb-E2F repression results in caspase-8-mediated apoptosis through inactivation of focal adhesion kinase.
    Lieman JH; Worley LA; Harbour JW
    J Biol Chem; 2005 Mar; 280(11):10484-90. PubMed ID: 15640164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired DNA damage checkpoint response in MIF-deficient mice.
    Nemajerova A; Mena P; Fingerle-Rowson G; Moll UM; Petrenko O
    EMBO J; 2007 Feb; 26(4):987-97. PubMed ID: 17290223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus EBNA-LP and transcription regulation properties of pRB, p107 and p53 in transfection assays.
    Inman GJ; Farrell PJ
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2141-9. PubMed ID: 7561751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.